We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+12.8%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.21B
AUM Growth
-$296M
Cap. Flow
-$592M
Cap. Flow %
-18.42%
Top 10 Hldgs %
43.24%
Holding
304
New
89
Increased
36
Reduced
82
Closed
88

Top Buys

Rank Stock Value
1
ATAI icon
AtaiBeckley Inc
ATAI
+$25.3M
2
AGL icon
Agilon Health
AGL
+$13.5M
3
LLY icon
Eli Lilly
LLY
+$13.2M
4
PRVA icon
Privia Health
PRVA
+$12.8M
5
LNTH icon
Lantheus
LNTH
+$12.3M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$23.9M
2
VCEL icon
Vericel Corp
VCEL
+$20.8M
3
ALGN icon
Align Technology
ALGN
+$19M
4
SIBN icon
SI-BONE Inc
SIBN
+$17.5M
5
STAA icon
STAAR Surgical
STAA
+$14.6M

Sector Composition

Rank Sector Weight
1 Healthcare 34.64%
2 Industrials 1.41%
3 Materials 0.54%
4 Financials 0.48%
5 Consumer Staples 0.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMGN
126
DELISTED
Immunogen Inc
IMGN
$4.54M 0.14%
689,049
-115,143
-14% -$803K
CORT icon
127
CALL
Corcept Therapeutics
CORT
$12B
$4.4M 0.14%
+200,000
New +$4.45M
LYRA
128
DELISTED
LYRA THERAPEUTICS INC
LYRA
$4.36M 0.14%
+10,853
New +$4.94M
OMIC
129
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$4.29M 0.13%
+5,202
New +$4.03M
ESTA icon
130
CALL
Establishment Labs
ESTA
$2.25B
$4.26M 0.13%
+48,800
New +$3.63M
MIST icon
131
Milestone Pharmaceuticals
MIST
$137M
$3.86M 0.12%
702,545
+234,905
+50% +$1.33M
DCPH
132
CALL
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$3.65M 0.11%
99,700
-1,500
-1% -$58.1K
VERV
133
DELISTED
Verve Therapeutics
VERV
$3.58M 0.11%
+59,393
New +$2.47M
CLDX icon
134
Celldex Therapeutics
CLDX
$3.51B
$3.51M 0.11%
105,056
-58,559
-36% -$1.61M
GKOS icon
135
PUT
Glaukos
GKOS
$10.6B
$3.39M 0.11%
+40,000
New +$3.28M
BEAM icon
136
Beam Therapeutics
BEAM
$2.77B
$3.22M 0.1%
+25,000
New +$1.99M
IMGN
137
CALL
DELISTED
Immunogen Inc
IMGN
$3.21M 0.1%
+487,700
New +$3.4M
CRBP icon
138
CALL
Corbus Pharmaceuticals
CRBP
$189M
$3.12M 0.1%
+56,760
New +$3.15M
ARQT icon
139
Arcutis Biotherapeutics
ARQT
$3.27B
$3.11M 0.1%
114,061
-31,683
-22% -$892K
DOCS icon
140
Doximity
DOCS
$4.49B
$2.91M 0.09%
+50,000
New +$2.81M
TRUP icon
141
PUT
Trupanion
TRUP
$1.37B
$2.88M 0.09%
+25,000
New +$2.17M
VINC
142
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$2.78M 0.09%
10,702
+3,226
+43% +$983K
TWST icon
143
PUT
Twist Bioscience
TWST
$7.65B
$2.67M 0.08%
+20,000
New +$2.33M
LHDX
144
DELISTED
Lucira Health, Inc. Common Stock
LHDX
$2.66M 0.08%
+400,000
New +$2.52M
SNTI icon
145
Senti Biosciences Holdings
SNTI
$11.2M
$2.48M 0.08%
+25,000
New +$2.49M
ARVN icon
146
Arvinas
ARVN
$576M
$2.43M 0.08%
31,543
-474
-1% -$32.9K
RCUS icon
147
CALL
Arcus Biosciences
RCUS
$3.68B
$2.42M 0.08%
88,000
+31,100
+55% +$888K
ABGI
148
DELISTED
ABG Acquisition Corp. I
ABGI
$2.38M 0.07%
242,770
-3,737
-2% -$37.1K
GLUE icon
149
Monte Rosa Therapeutics
GLUE
$1.38B
$2.27M 0.07%
+100,000
New +$2.04M
PSNL icon
150
CALL
Personalis
PSNL
$1.49B
$2.21M 0.07%
+87,500
New +$2M
4 5
6
7 8

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q2 2021 Portfolio in Review

As of Q2 2021, Pura Vida Investments held 304 positions worth $3.21B, down 8.4% from $3.51B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Pura Vida Investments withdrew a net $592M in Q2 2021, closing 88 positions and reducing 82 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $23.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Industrials and Materials.

Against the trend, Pura Vida Investments opened a new position in AtaiBeckley Inc worth $23.2M.

  • Pura Vida Investments's largest Q2 2021 buy was AtaiBeckley Inc: 1,371,824 shares worth $23.2M.
  • Pura Vida Investments added most to Quotient Limited Ordinary Shares in Q2 2021, an estimated $9.15M increase.
  • Pura Vida Investments's biggest Q2 2021 reduction was STAAR Surgical, cutting an estimated $14.6M.
  • Pura Vida Investments fully exited Alexion Pharmaceuticals in Q2 2021, selling an estimated $23.9M.
  • Pura Vida Investments's ten largest holdings make up 43% of its $3.21B portfolio in Q2 2021.
  • Pura Vida Investments opened 89 new positions and closed 88 in Q2 2021.
  • Pura Vida Investments's portfolio value fell 8.4% quarter-over-quarter to $3.21B.

Based on Pura Vida Investments's 13F filing for Q2 2021, filed 16 Aug 2021.